# Eviora MD reviews (2026): GLP-1 telehealth sellers | This GLP Three GLP-1 programs, each marked available by consultation, from a Virginia telehealth practice that quotes a flat rate only after a provider has reviewed the case. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/eviora-md Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Priced at consultation # Eviora MD review Three GLP-1 programs, each marked available by consultation, from a Virginia telehealth practice that quotes a flat rate only after a provider has reviewed the case. ## The verdict Eviora MD offers compounded semaglutide, compounded tirzepatide and a lower-dose GLP-1 microdose program, and each treatment page says "Available by consultation" in the place where a buyer would look for a price. A new-patient banner on the homepage carries a monthly from-figure, but it names no drug and says the plan is confirmed after provider review, so nothing on the site works as a price for either molecule. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection Prescription Required Compounded Yes — not FDA-approved Pharmacy Not named Availability All 50 states Eviora MD describes itself as a concierge telehealth platform based in Henrico, Virginia, connecting patients with independent board-certified providers and state-licensed compounding pharmacies. Next to its three GLP-1 programs it lists NAD+ and other peptide therapies, and its about page claims service in all 50 states. The site runs on software shared with other GLP-1 storefronts, which is why its pages may look familiar. 1. ## Who writes the prescription, and what do they see? The platform says plainly that it does not practice medicine or write prescriptions, and that every clinical decision rests with an independent licensed practitioner. No practitioner or medical group is named on the treatment pages, so a patient finds out who is prescribing only once the consultation itself begins. A patient starts with a short online eligibility check, moves on to a consultation, and, if a provider authorizes treatment, receives a protocol prepared by a partner pharmacy, with structured check-ins and secure messaging after it arrives. Memberships can be canceled with 30 days' notice before the next billing cycle, while consultations and filled prescriptions become non-refundable once they begin. 2. ## What happens when the dose goes up? The treatment pages call every program flat-rate, with "no dose-change surcharges", which would mean the monthly figure holds as the dose is stepped up over the first several months. Because that figure is never published, the promise can only be tested after the consultation, when the quote arrives and can be kept in writing for the months that follow. 3. ## What the price includes No rate is published for any GLP-1 line, and the pages come close to saying so outright, promising that the quoted price is the price paid. The banner's from-figure covers GLP-1 programs in general and is confirmed only after provider review, so it cannot be pinned to semaglutide, tirzepatide or the microdose line. Someone comparing sellers has nothing from this one to set beside the others until a consultation has been booked and held. 4. ## What it claims, and what it cites Every GLP-1 program is prepared by partner compounding pharmacies in the United States, none of which is named. The site's own disclaimer says compounded medications are not FDA-approved, and that their safety, efficacy and quality have not been independently verified by the agency. That disclaimer sits at the foot of every page rather than only in the terms. ## Where it holds up, and where it does not - Strength: No dose-change surcharge is promised - Strength: Nothing charged if a patient is not approved - Strength: Cancellation notice period stated up front - Strength: Compounded status disclosed on every page - Limitation: No price published for any GLP-1 line - Limitation: No prescriber or medical group named - Limitation: Compounding pharmacy is not named - Limitation: Filled prescriptions cannot be refunded ## What the evidence says about this kind of treatment The assessment above is about Eviora MD. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A buyer prepared to sit through a consultation before seeing any figure for the drug, and to hold the practice to its flat-rate promise afterward. Wrong for A buyer who wants to line up published monthly prices across several sellers before starting anything. ## The evidence behind what Eviora MD prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Eviora MD compares | Seller | Who it suits | Go | | --- | --- | --- | | Superior Remedies | Readers willing to book a consultation before learning any figure | | | MultiMedRx | A reader with insurance who needs a branded GLP-1 covered rather than sold | | | Vytora Health | Buyers expecting several dose steps who want the bill to stay flat | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Mevo Health](https://thisglp.com/reviews/mevo-health) [Midi Health](https://thisglp.com/reviews/midi-health) [Mint Med](https://thisglp.com/reviews/mint-med) [Mint Medical Clinic](https://thisglp.com/reviews/mint-medical) [Mochi Health](https://thisglp.com/reviews/mochi-health) [Mojoon](https://thisglp.com/reviews/mojoon) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked How much does semaglutide cost here? Eviora MD does not publish it. The semaglutide page says "Available by consultation", and a quote follows once a provider has reviewed the case. What does the homepage banner's price cover? It is a new-patient offer for GLP-1 programs in general. It names no molecule, and the site says plans are confirmed after provider review. Can a membership be canceled? Yes, with 30 days' notice before the next billing cycle. Consultations, visits and prescriptions already processed are not refunded. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).